JP2012518417A - Ｐａ−ｃａｒｄを用いて癌を予防及び／又は治療するための組成物及び方法 - Google Patents

Ｐａ−ｃａｒｄを用いて癌を予防及び／又は治療するための組成物及び方法 Download PDF

Info

Publication number
JP2012518417A
JP2012518417A JP2011551270A JP2011551270A JP2012518417A JP 2012518417 A JP2012518417 A JP 2012518417A JP 2011551270 A JP2011551270 A JP 2011551270A JP 2011551270 A JP2011551270 A JP 2011551270A JP 2012518417 A JP2012518417 A JP 2012518417A
Authority
JP
Japan
Prior art keywords
cells
laz
card
cell
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011551270A
Other languages
English (en)
Japanese (ja)
Inventor
グプタ，タパス ダス
チャクラバーティー，アナンダ
フィアーリョ，アルセニオ
Original Assignee
シーディージー セラピューティクス，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シーディージー セラピューティクス，インコーポレイテッド filed Critical シーディージー セラピューティクス，インコーポレイテッド
Publication of JP2012518417A publication Critical patent/JP2012518417A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2011551270A 2009-02-20 2010-02-22 Ｐａ−ｃａｒｄを用いて癌を予防及び／又は治療するための組成物及び方法 Pending JP2012518417A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15423609P 2009-02-20 2009-02-20
US61/154,236 2009-02-20
US17943509P 2009-05-19 2009-05-19
US61/179,435 2009-05-19
PCT/US2010/024904 WO2010096754A1 (en) 2009-02-20 2010-02-22 Compositions and methods to prevent and/or treat cancer with pa -card

Publications (1)

Publication Number Publication Date
JP2012518417A true JP2012518417A (ja) 2012-08-16

Family

ID=42634238

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011551270A Pending JP2012518417A (ja) 2009-02-20 2010-02-22 Ｐａ−ｃａｒｄを用いて癌を予防及び／又は治療するための組成物及び方法

Country Status (9)

Country Link
EP (1) EP2398486A4 (de)
JP (1) JP2012518417A (de)
KR (1) KR20120000062A (de)
CN (1) CN102387809A (de)
AU (1) AU2010215858A1 (de)
CA (1) CA2753121A1 (de)
IL (1) IL214757A0 (de)
SG (1) SG174136A1 (de)
WO (1) WO2010096754A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016514086A (ja) * 2013-02-05 2016-05-19 アグリカルチュラル テクノロジー リサーチ インスティテュート 抗マイコプラズマ属菌種サブユニットワクチン

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2913805A1 (en) 2005-11-07 2007-05-18 Indiana University Research And Technology Corporation Glucagon analogs exhibiting physiological solubility and stability
WO2014049604A2 (en) * 2012-09-05 2014-04-03 Amrita Therapeutics Limited A novel biomedical device for cancer therapy
CN103554187B (zh) * 2013-09-18 2016-03-30 中国科学技术大学 铂类配合物、由该铂类化合物制得的蛋白质复合物及其制备方法
USD844857S1 (en) * 2017-10-05 2019-04-02 Western Interlock, Inc. Retaining wall corner block

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002535001A (ja) * 1999-01-26 2002-10-22 ユニバーシテイ・カレツジ・ロンドン スクリーニング方法
US20020164703A1 (en) * 2000-12-21 2002-11-07 Krzysztof Pawlowski Card-domain containing polypeptides, encoding nucleic acids, and methods of use
GB0211295D0 (en) * 2002-05-16 2002-06-26 Univ London Treatment of pain
EP1797114A4 (de) * 2004-10-07 2009-07-15 Ananda Chakrabarty Aus cupredoxin abgeleitete transportmittel und verfahren zu ihrer verwendung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016514086A (ja) * 2013-02-05 2016-05-19 アグリカルチュラル テクノロジー リサーチ インスティテュート 抗マイコプラズマ属菌種サブユニットワクチン

Also Published As

Publication number Publication date
WO2010096754A8 (en) 2011-04-28
IL214757A0 (en) 2011-11-30
SG174136A1 (en) 2011-10-28
EP2398486A1 (de) 2011-12-28
KR20120000062A (ko) 2012-01-03
WO2010096754A1 (en) 2010-08-26
CN102387809A (zh) 2012-03-21
AU2010215858A1 (en) 2011-09-22
EP2398486A4 (de) 2012-11-21
CA2753121A1 (en) 2010-08-26

Similar Documents

Publication Publication Date Title
US8545812B2 (en) Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof
KR20090095626A (ko) 쿠프레독신과 ＣｐＧ 리치 ＤＮＡ를 이용한 조성물 및 암 치료 방법
Orange et al. Cell penetrating peptide inhibitors of nuclear factor-kappa B
EP1856145B1 (de) Zusammensetzungen des spannungsabhängigen anionenkanals (vdac1) und verfahren zu deren anwendung bei der regulierung der apoptose
CN102665748A (zh) 使用muc1拮抗剂抑制炎症
AU2010249705A1 (en) Compositions and methods to prevent cancer by stabilizing p53 through non MDM2-mediated pathways
MX2007014598A (es) Composiciones y metodos para tratar condiciones relacionadas con senalizacion de efrina con cupredoxinas.
JP2012518417A (ja) Ｐａ−ｃａｒｄを用いて癌を予防及び／又は治療するための組成物及び方法
KR20110128878A (ko) 큐프레독신 유래 펩티드의 변형 및 이의 사용방법
CA2747192A1 (en) Compositions and methods to prevent cancer with cupredoxins
EP2004680B1 (de) N-terminale vdac-varianten und anwendungen davon
US10072049B2 (en) Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
KR20080024124A (ko) 쿠프레독신과 시토크롬 ｃ로 ｈｉｖ 감염을 치료하기 위한조성물과 방법
JP2009504567A (ja) クプレドキシンおよびシトクロムでマラリアを治療するための組成物および方法
US20100278937A1 (en) Compositions and methods to prevent and/or treat cancer with pa-card
AU2009333174A1 (en) Compositions and methods to prevent cancer with cupredoxins
IL194466A (en) Variants of the V-N terminal of VDAC and their use